Results 271 to 280 of about 423,816 (314)

Deep learning to estimate response of concurrent chemoradiotherapy in non-small-cell lung carcinoma. [PDF]

J Transl Med
Peng J, Zhang X, Hu Y, He T, Huang J, Zhao M, Meng J.   +6 more
europepmc   +1 more source

Correlation between Periostin Expression and Pro-Angiogenic Factors in Non-Small-Cell Lung Carcinoma. [PDF]

Cells
Wasik A, Podhorska-Okolow M, Dziegiel P, Piotrowska A, Kulus MJ, Kmiecik A, Ratajczak-Wielgomas K.   +6 more
europepmc   +1 more source

Laminin-γ2-NR6A1 Fusion Protein Promotes Metastatic Potential in Non-Small-Cell Lung Carcinoma Cells without Epidermal Growth Factor Receptor Mutation. [PDF]

Am J Pathol
Kaneko R, Kishimoto Y, Ishikawa O, Funahashi N, Koshikawa N.   +4 more
europepmc   +1 more source

Clinical effectiveness of Anlotinib combined with PD-1 inhibitors in treating advanced non-small-cell lung carcinoma. [PDF]

Am J Transl Res
Han Z, Liu W, Wang F.
europepmc   +1 more source

E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma.

, 2015
Li Chen, Jian Yu, Zhi Hui Lu, Wei Zhang
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Non-Small-Cell Lung Carcinoma

Drugs, 1995
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies in developed countries and accounts for millions of deaths worldwide. The incidence of NSCLC correlates with smoking tobacco and is likely to increase in those countries with increasing per capita consumption of tobacco.
K T, Bastin, R, Curley
openaire   +2 more sources

Breast Metastasis from Non-Small-Cell Lung Carcinoma

Medical Oncology, 2003
Development of metastasis to the breast from lung cancer is very rare and the prognosis for such patients is poor. We present a patient who had metastasis to breast from non-small-cell lung cancer. It is important to distinguish a primary breast cancer from metastasis to the breast, as the therapy offered would be markedly different, with considerably ...
Kannan, Ramar, Hassan, Pervez, Anil, Potti, Syed, Mehdi   +3 more
openaire   +2 more sources

Molecular Diagnostics in Non-Small Cell Lung Carcinoma

Seminars in Respiratory and Critical Care Medicine, 2020
AbstractCurrent clinical practice guidelines recognize EGFR, BRAF, ALK, and ROS1 as essential molecular biomarkers, and a host of other genetic alterations as emerging biomarkers for non-small cell lung carcinoma patients. The available approaches to detecting relevant alterations in these genes are diverse and often complementary.
openaire   +2 more sources

Paraneoplastic mononeuritis multiplex in non-small-cell lung carcinoma

Journal of Clinical Neuroscience, 2006
A 60-year-old man developed two selective peripheral mononeuropathies of the peroneal and later the radial nerve, shortly after a diagnosis of large-cell lung carcinoma. Nerve conduction studies and electromyography confirmed isolated lesions in both nerves, and in the case of the peroneal nerve lesion, focal conduction block was localised to the level
Annabel C, Martin, Michael, Friedlander, Matthew C, Kiernan   +2 more
openaire   +2 more sources